Table 1.
Description of study population according to GMFCS classification as mild, moderate, and severe impairment groups
| GMFCS | Total | ||||
|---|---|---|---|---|---|
| Mild | Moderate | Severe | |||
| Number of participants | n = 6 | n = 3 | n = 63 | N = 72 | |
| Mean (SD) age in months | 14.5 (1.4) | 11.7 (0.6) | 14.1 (4.7) | 13.9 (4.4) | |
| Sex | Female | 3 (50.0%) | 1 (33.3%) | 29 (46.0%) | 33 (45.8%) |
| Male | 3 (50.0%) | 2 (66.7%) | 34 (54.0%) | 39 (54.2%) | |
| Microcephaly | Yes | 2 (33.3%) | 0 | 51 (81.0%) | 53 (73.6%) |
| No | 4 (66.7%) | 3 (100%) | 12 (19.0%) | 19 (26.4%) | |
| Microcephaly severity | Moderate | 1 (50.0%) | 0 | 16 (31.4%) | 17 (32.1%) |
| Severe | 1 (50.0%) | 0 | 35 (68.6%) | 36 (67.9%) | |
|
ZIKV detection (RT-PCR) |
Yes | 4 (66.7%) | 2 (66.7%) | 25 (39.7%) | 31 (43%) |
| No | 2 (33.3%) | 1 (33.3%) | 38 (60.3%) | 41 (57%) | |
| Physical therapy | Yes | 4 (66.7%) | 3 (100%) | 56 (88.9%) | 65 (87.5%) |
| No | 2 (33.3%) | 0 | 7 (11.1%) | 9 (12.5%) | |
| GMFCS levels |
I = 0 II = 6 |
II = 3 |
IV = 42 V = 21 |
– | |
| Mean (SD) GMFM | 81.6 (5.9) | 26.1 (7.0) | 11.6 (3.6) | 17.6 (20.2) | |
GMFCS, gross motor function classification system; RT-PCR, reverse transcription-polymerase chain reaction; ZIKV, Zika virus